Roflo, Teresita G.

HRN: 27-29-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2025
CEFTRIAXONE 1G (VIAL)
06/10/2025
06/16/2025
IVT
2g
OD
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines